How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?
Désirée Erlinda Larenas-LinnemannBlanca María Morfín-MacielPublished in: Expert review of respiratory medicine (2023)
Clear indications for AIT in asthma guidelines would benefit allergic asthmatics. AIT is a therapeutic option in appropriately selected asthmatics. Three years treatment has the potential for long-term tolerance, with persisting benefits years after discontinuation.